Pharma Buying Spree Continues As AbbVie Takes Out Allergan For $63 BillionInvestors Business Daily • 06/25/19
AbbVie (ABBV) Stock Falls After $63 Billion Allergan Acquisition AnnouncementZacks Investment Research • 06/25/19
Dow Jones Futures: From AMD To Zoom Video, Growth Stocks Offer Warning; AbbVie To Buy AllerganInvestors Business Daily • 06/25/19
AbbVie confirms deal to buy Allergan for 45% premium, valuing Allergan at $61.7 billionMarket Watch • 06/25/19
Allergan's stock soars after WSJ report AbbVie near a buyout deal for a 45% premiumMarket Watch • 06/25/19